[1]
2021. Phase IV Evaluation of the Adrenal Suppression Potential and PKPD of Halobetasol Propionate Foam, 0.05% in Adolescent Subjects with Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s47. DOI:https://doi.org/10.25251/skin.5.supp.47.